Shuiyi Liu

1.3k total citations
23 papers, 991 citations indexed

About

Shuiyi Liu is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Shuiyi Liu has authored 23 papers receiving a total of 991 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 17 papers in Cancer Research and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Shuiyi Liu's work include MicroRNA in disease regulation (12 papers), Cancer-related molecular mechanisms research (10 papers) and Circular RNAs in diseases (9 papers). Shuiyi Liu is often cited by papers focused on MicroRNA in disease regulation (12 papers), Cancer-related molecular mechanisms research (10 papers) and Circular RNAs in diseases (9 papers). Shuiyi Liu collaborates with scholars based in China, United States and Malaysia. Shuiyi Liu's co-authors include Zhongxin Lu, Tangwei Wu, Weiqun Chen, Hui Hu, Xiaoyi Li, Deyong Kong, Yong Ning, Heming Chen, Hui Wang and Yong Li and has published in prestigious journals such as Scientific Reports, FEBS Letters and Gene.

In The Last Decade

Shuiyi Liu

23 papers receiving 976 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuiyi Liu China 16 727 651 121 108 89 23 991
Suet‐Ying Kwan United States 13 821 1.1× 561 0.9× 105 0.9× 160 1.5× 51 0.6× 24 1.1k
Wu Sun China 15 784 1.1× 665 1.0× 61 0.5× 77 0.7× 79 0.9× 26 989
Guoyong Han China 16 550 0.8× 368 0.6× 174 1.4× 144 1.3× 50 0.6× 31 819
Zerong Cai China 10 1.0k 1.4× 750 1.2× 71 0.6× 125 1.2× 65 0.7× 25 1.2k
Shengjie Wang China 16 812 1.1× 592 0.9× 54 0.4× 135 1.3× 49 0.6× 39 1.0k
Chengtao Yu China 14 1.2k 1.7× 974 1.5× 76 0.6× 72 0.7× 64 0.7× 27 1.4k
Meryem Gülfem Öner Germany 7 816 1.1× 766 1.2× 188 1.6× 296 2.7× 86 1.0× 7 1.3k

Countries citing papers authored by Shuiyi Liu

Since Specialization
Citations

This map shows the geographic impact of Shuiyi Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuiyi Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuiyi Liu more than expected).

Fields of papers citing papers by Shuiyi Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuiyi Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuiyi Liu. The network helps show where Shuiyi Liu may publish in the future.

Co-authorship network of co-authors of Shuiyi Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Shuiyi Liu. A scholar is included among the top collaborators of Shuiyi Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuiyi Liu. Shuiyi Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Heming, Xiaoyi Li, Weiqun Chen, Tangwei Wu, & Shuiyi Liu. (2024). LncRNA HOTAIR Inhibits miR-19a-3p to Alleviate Foam Cell Formation and Inflammatory Response in Atherosclerosis. International Journal of Medical Sciences. 21(3). 521–529. 5 indexed citations
2.
Wu, Tangwei, et al.. (2023). Huaier suppresses cell viability, migration and invasion in human non-small cell lung cancer via lncRNA DLEU2/miR-212-5p/ELF3 axis. International Journal of Medical Sciences. 21(2). 319–331. 1 indexed citations
3.
Liu, Shuiyi, Weiqun Chen, Hui Hu, et al.. (2021). Long noncoding RNA PVT1 promotes breast cancer proliferation and metastasis by binding miR-128-3p and UPF1. Breast Cancer Research. 23(1). 115–115. 24 indexed citations
4.
Tan, Zheqiong, Man Zhu, Zhenzhao Luo, et al.. (2021). Carnitine palmitoyl transferase 1A is a novel diagnostic and predictive biomarker for breast cancer. BMC Cancer. 21(1). 409–409. 29 indexed citations
5.
Luo, Zhenzhao, et al.. (2021). MiR-188-3p and miR-133b Suppress Cell Proliferation in Human Hepatocellular Carcinoma via Post-Transcriptional Suppression of NDRG1. Technology in Cancer Research & Treatment. 20. 2203774962–2203774962. 16 indexed citations
6.
Wang, Hui, Hui Hu, Zhenzhao Luo, et al.. (2020). miR-4454 up-regulated by HPV16 E6/E7 promotes invasion and migration by targeting ABHD2/NUDT21 in cervical cancer. Bioscience Reports. 40(9). 14 indexed citations
7.
Li, You, Hui Hu, Yan Ge, et al.. (2020). Evaluation of models for predicting the probability of malignancy in patients with pulmonary nodules. Bioscience Reports. 40(2). 6 indexed citations
8.
Li, You, Yibin Zhang, Hui Hu, et al.. (2020). Colorectal Cancer Screening Methods and Molecular Markers for Early Detection. Technology in Cancer Research & Treatment. 19. 1079248074–1079248074. 41 indexed citations
9.
Wang, Hui, Zheqiong Tan, Hui Hu, et al.. (2019). microRNA-21 promotes breast cancer proliferation and metastasis by targeting LZTFL1. BMC Cancer. 19(1). 738–738. 215 indexed citations
10.
Hu, Hui, Qin Zhang, Weiqun Chen, et al.. (2019). MicroRNA-301a promotes pancreatic cancer invasion and metastasis through the JAK/STAT3 signaling pathway by targeting SOCS5. Carcinogenesis. 41(4). 502–514. 51 indexed citations
11.
Wu, Tangwei, Hui Hu, Tianzhu Zhang, et al.. (2019). miR-25 Promotes Cell Proliferation, Migration, and Invasion of Non-Small-Cell Lung Cancer by Targeting the LATS2/YAP Signaling Pathway. Oxidative Medicine and Cellular Longevity. 2019. 1–14. 53 indexed citations
12.
Chen, Xiaoli, Hesheng Luo, Xiaoyi Li, et al.. (2018). miR-331-3p functions as an oncogene by targeting ST7L in pancreatic cancer. Carcinogenesis. 39(8). 1006–1015. 38 indexed citations
13.
Chen, Heming, et al.. (2017). MircroRNA-19a promotes vascular inflammation and foam cell formation by targeting HBP-1 in atherogenesis. Scientific Reports. 7(1). 12089–12089. 55 indexed citations
14.
Li, Xiaoyi, Deyong Kong, Heming Chen, et al.. (2016). miR-155 acts as an anti-inflammatory factor in atherosclerosis-associated foam cell formation by repressing calcium-regulated heat stable protein 1. Scientific Reports. 6(1). 21789–21789. 133 indexed citations
15.
Wang, Hui, Shuiyi Liu, Tangwei Wu, et al.. (2015). Expression of miR-145 in breast cancer and its role in invasion and migration of breast cancer cells. Zhonghua jianyan yixue zazhi. 38(3). 186–190. 1 indexed citations
16.
Liu, Shuiyi, et al.. (2015). microRNA-218 expression and its association with the clinicopathological characteristics of patients with cervical cancer. Experimental and Therapeutic Medicine. 10(1). 269–274. 16 indexed citations
17.
18.
Wu, Tangwei, Weiqun Chen, Deyong Kong, et al.. (2015). miR-25 targets the modulator of apoptosis 1 gene in lung cancer. Carcinogenesis. 36(8). 925–935. 62 indexed citations
19.
Wu, Tangwei, Weiqun Chen, Shuiyi Liu, et al.. (2014). Huaier suppresses proliferation and induces apoptosis in human pulmonary cancer cells via upregulation of miR‐26b‐5p. FEBS Letters. 588(12). 2107–2114. 70 indexed citations
20.
Chen, Weiqun, Hui Wang, Heming Chen, et al.. (2014). Clinical significance and detection of microRNA‐21 in serum of patients with diffuse large B‐cell lymphoma in Chinese population. European Journal Of Haematology. 92(5). 407–412. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Suet‐Ying Kwan Breakdown of academic impact, for papers by Wu Sun Breakdown of academic impact, for papers by Guoyong Han Breakdown of academic impact, for papers by Zerong Cai Breakdown of academic impact, for papers by Shengjie Wang Breakdown of academic impact, for papers by Chengtao Yu Breakdown of academic impact, for papers by Meryem Gülfem Öner
Rankless by CCL
2026